MARTINI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 3.007
NA - Nord America 1.221
AS - Asia 1.191
SA - Sud America 236
AF - Africa 34
OC - Oceania 5
Totale 5.694
Nazione #
IT - Italia 1.393
US - Stati Uniti d'America 1.156
RU - Federazione Russa 977
SG - Singapore 344
CN - Cina 331
BR - Brasile 192
SE - Svezia 148
HK - Hong Kong 139
NL - Olanda 123
JP - Giappone 111
VN - Vietnam 104
DE - Germania 77
FR - Francia 68
IN - India 57
GB - Regno Unito 46
CA - Canada 38
FI - Finlandia 37
TR - Turchia 35
ES - Italia 23
MX - Messico 23
PL - Polonia 21
AT - Austria 17
AR - Argentina 15
BD - Bangladesh 13
IQ - Iraq 12
LT - Lituania 11
ZA - Sudafrica 11
CO - Colombia 9
CZ - Repubblica Ceca 9
UA - Ucraina 9
CH - Svizzera 8
IE - Irlanda 7
NO - Norvegia 6
DK - Danimarca 5
MA - Marocco 5
NG - Nigeria 5
PE - Perù 5
PK - Pakistan 5
AU - Australia 4
BG - Bulgaria 4
CL - Cile 4
DZ - Algeria 4
EC - Ecuador 4
GR - Grecia 4
ID - Indonesia 4
IL - Israele 4
PH - Filippine 4
PT - Portogallo 4
UZ - Uzbekistan 4
BE - Belgio 3
EG - Egitto 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
CY - Cipro 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PY - Paraguay 1
UY - Uruguay 1
Totale 5.694
Città #
Ashburn 253
Milan 237
Singapore 198
Moscow 173
Dallas 152
Hong Kong 136
Rome 115
San Jose 94
New York 89
Shanghai 72
Beijing 61
Los Angeles 46
Hefei 41
Verona 38
Turin 37
Boardman 36
Lauterbourg 34
Ho Chi Minh City 33
Munich 33
Tokyo 32
Bologna 30
Lawrence 28
Princeton 28
Florence 26
Genoa 23
Hanoi 23
São Paulo 23
Orem 22
Pune 21
Brooklyn 20
Helsinki 20
Bari 18
Montreal 16
Palermo 16
Frankfurt am Main 15
Warsaw 14
Catania 13
Chennai 13
Denver 13
Amsterdam 12
Phoenix 12
Turku 12
Azzano San Paolo 11
Bolzano 11
Naples 11
Santa Clara 10
The Dalles 10
Toronto 10
Chicago 9
Da Nang 9
Manchester 9
Mexico City 9
Paris 9
Vienna 9
Brescia 8
Council Bluffs 8
Houston 8
Trieste 8
Ankara 7
Atlanta 7
Bergamo 7
Bursa 7
Columbus 7
Dublin 7
Guangzhou 7
Johannesburg 7
Lamezia Terme 7
London 7
Modena 7
Mumbai 7
Nuremberg 7
Padova 7
Porto Alegre 7
Haiphong 6
Hayamiya 6
Istanbul 6
Montepulciano 6
Parma 6
Poplar 6
Rio de Janeiro 6
Stockholm 6
Venice 6
Andria 5
Erbil 5
Falconara Marittima 5
Pavia 5
Prato 5
Treviso 5
Arcore 4
Barnet 4
Brasília 4
Buffalo 4
Casablanca 4
Cascina 4
Cesano Boscone 4
Lappeenranta 4
Melbourne 4
Novara 4
Oslo 4
Passo Fundo 4
Totale 2.714
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.821
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 162
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 155
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 133
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 130
How to Select the Optimal Candidates for Renal Mass Biopsy 125
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 121
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 119
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 118
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 116
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 113
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 112
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 110
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 109
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 107
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 107
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 103
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 101
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 99
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 99
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 93
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 93
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 92
Citrullination licenses calpain to decondense nuclei in neutrophil extracellular trap formation 90
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 90
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 89
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 88
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 87
The obesity paradox in metastatic castration-resistant prostate cancer 86
Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impact of Age at the Time of Surgery 85
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 85
A Plea for Economically Sustainable Evidence-based Guidelines 85
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 78
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 66
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 63
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 60
UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment of Penile Cancer 60
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 58
RE: Validating the Martini Staging System for Rectourethral Fistula: A Meta-analysis of Postoperative Outcomes 51
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 51
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 50
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients 48
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 44
Surgical repair of post-cesarean vesicouterine fistula: A systematic review and a plea for prevention 2
null 1
Totale 5.755
Categoria #
all - tutte 21.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022109 0 9 1 18 7 6 14 11 5 9 17 12
2022/2023385 74 60 28 21 21 58 27 41 20 5 18 12
2023/2024751 18 21 31 50 53 133 41 156 12 60 71 105
2024/20251.478 163 64 128 75 87 124 202 164 189 97 74 111
2025/20263.020 243 198 192 422 305 119 270 277 836 158 0 0
Totale 5.755